drugset / Trial / NCT05138770
Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects
RandomizedSequentialDouble-blindTreatment
Summary
This clinical trial consists of two parts:1. a randomized, double-blind, single-center, placebo-controlled, dose-escalation PK study; 2. food effects and drug metabolism transformation study. The main purpose of this trial is to evaluate the Safety, Tolerance, Pharmacokinetics, Pharmacodynamics and Food effects of VC005 Tablets in healthy subjects.
Timeline
- Start
- 2021-11-18
- Primary completion
- 2022-08-26
- Completion
- 2022-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VC005 | Unknown | 1 mg | — |
| Subject | VC005 | Unknown | 5 mg | — |
| Subject | VC005 | Unknown | 10 mg | — |
| Subject | VC005 | Unknown | 25 mg | — |
| Subject | VC005 | Unknown | 50 mg | — |
| Subject | VC005 | Unknown | 100 mg | — |